Price Target: EUR (20.60) 07 April 2011 Solid FY10 & More to come

Similar documents
Price Target: EUR 4.15 (3.80)

Price Target: EUR (20.00) 04 April 2012 FY11 results: No surprises so far

Price Target: EUR (22.00)

Price Target: EUR (17.00)

Solid preliminary FY 2014 results released. Net asset value increased by 3.5% in H 2014 with difficult trading environment

Price Target: EUR 1.60 (1.50)

Price Target: EUR 5.00 (5.00)

Borussia Dortmund GmbH & Co. KGaA

Price Target: EUR 1.30 (1.30)

Borussia Dortmund GmbH & Co KGaA

Price Target: EUR (50.00)

Price Target: EUR (35.00)

Borussia Dortmund GmbH & Co KGaA

Borussia Dortmund GmbH & Co. KGaA

Borussia Dortmund GmbH & Co. KGaA

Price target: EUR (20.00) 15 August 2014 Final 2Q figures match preliminary figures

Borussia Dortmund GmbH & Co KGaA

PrimeCity Investment Plc

Price Target: EUR (19.00)

BUY (previous: BUY) (previous: 77.50)

Reduced EPS but smart acquisition

Key ratios Sales adj. net

Evaluation result Fair value DPS. adj. net. adj. EPS ( )

Electronics Line 3000 Ltd.

PA Power Automation AG

NOT RATED. (previously Buy) (previously 1.73) adj. net (mln ) DPS ( ) adj. EPS ( )

QUIRIN PRIVATBANK EQUITY RESEARCH

Strong growth ahead QUIRIN PRIVATBANK EQUITY RESEARCH. 18 Mai 2017 EQS Group AG

PA Power Automation AG

HOLD 51,85. (previous: Hold) (previous: 51,65)

TEMPORARILY NO VALUATION. (previous: not rated)

Buy PT EUR24,00, upside 23%

Financials/Prime Standard

HOLD (previous: BUY) (previous: 68.00)

Research Note. Fair Value REIT-AG

HAEMATO AG SOLID UPTICK IN H2 SALES AND EBIT MARGIN. FIRST BERLIN Equity Research PRICE TARGET H A

Highest single order in paragon s history

Evaluation result Fair value BUY (prev.: BUY) (prev.: 21.52)

BUY (previous: BUY) (previous: 3.70)

ISRA VISION Neutral

HOLD (previous: Hold) (previous: 51.85)

1 November 2017 M1 Kliniken AG. FIRST BERLIN Equity Research. Update following

- 2/7 - Segment Discussion August 05, Segment Discussion. Stock and Valuation

Evaluation Result Fair Value BUY (previous: BUY) (previous: 65.50)

BUY (previous: BUY) (previous: 72.30) DPS ( ) adj. EPS ( )

Klaus Kränzle, Please inform yourself of important disclosures and disclaimers in the appendix

13 May 2016 PNE WIND AG. FIRST BERLIN Equity Research

CLERE AG DELISTING & TAKEOVER BID BY MAIN SHAREHOLDER. FIRST BERLIN Equity Research. Delisting & PRICE TARGET C L

The growth story continues

All for One Steeb AG August 13, 2013

BDI BioEnergy Internat Buy

Leifheit AG. Management Meeting confirms our positive view. Buy (Buy) EUR (60.00 EUR ) BANKHAUS LAMPE // 1 16/02/2016

Geratherm Medical AG Strong demand in Q3

17 May 2016 ISARIA Wohnbau AG. FIRST BERLIN Equity Research

Buy PT 24,00, upside 23%

BUY (previous: BUY) (previous: 75.65)

Intershop Communications AG

Advanced Vision Techn Buy

18 October 2016 aventron AG. FIRST BERLIN Equity Research

SFC Energy AG STRONG GROWTH AND PROFITABILITY AHEAD. FIRST BERLIN Equity Research. Preliminary PRICE TARGET S F

BUY (previous: BUY) (previous: 3.40)

MATELAN Research. InVision 49.0 Buy. Excellent margin trend in Prelims. Update Note. 24 February Company / Sector Fair Value Recommendation

Indygotech Minerals S.A.

BUY (previous: BUY) (previous: 2.20)

Tel.: +49 (0) Tel.: +49 (0)

18 November 2016 Energiekontor AG. FIRST BERLIN Equity Research

Adler Real Estate AG. Fewer vacancies, more properties. Buy (Buy) EUR (16.50 EUR ) BANKHAUS LAMPE // 1 28/03/2017

HAEMATO AG MARKET SHARE WIN IN PARALLEL IMPORT BUSINESS. FIRST BERLIN Equity Research H1/18 PRICE TARGET H A

26 April 2017 aventron AG. FIRST BERLIN Equity Research

14 August 2017 PNE WIND AG. FIRST BERLIN Equity Research

ad pepper media International N.V.

14 September 2017 Pharming Group NV. FIRST BERLIN Equity Research. Update. Bloomberg: PHARM NA Return Potential 216.5% ISIN: NL

6 September 2016 aventron AG. FIRST BERLIN Equity Research

22 November 2017 Energiekontor AG. FIRST BERLIN Equity Research

PNE WIND AG OFFSHORE PROJECT ATLANTIS I SOLD. FIRST BERLIN Equity Research. Good start to PRICE TARGET P N

20 April 2018 Energiekontor AG. FIRST BERLIN Equity Research

adesso AG November 5, 2012

27 March 2019 SFC Energy AG. FIRST BERLIN Equity Research. Final SUSTAINABLE MACRO TRENDS SUPPORT FUEL CELL BUSINESS

Very solid Q3; excellent story, but priced in; TP upped to 60.00; downgrade to neutral. Q3 2016: Very solid quarter, better than expected

24 May 2016 Energiekontor AG. FIRST BERLIN Equity Research

5 September 2016 OTI Greentech AG. FIRST BERLIN Equity Research

adesso AG MAY 31, 2012

18 January 2018 Pharming Group NV. FIRST BERLIN Equity Research. Update. Bloomberg: PHARM NA Return Potential 45.9% ISIN: NL

14 November 2018 M1 Kliniken AG. FIRST BERLIN Equity Research. H1/18 figures &

Air France-KLM. Hold TP 6.50 CP 7.59 (Close 21 October 2013) Q3 due 31 October More restructuring needed. Equity Research Quick Bite Preview

Advanced Vision Technology

Schloss Wachenheim AG

Net income (after min.) >100% EPS [ ] (0.63) (0.27) >100% 0.20 (1.85)

11 January 2018 Deutsche Rohstoff AG. FIRST BERLIN Equity Research. Update. Bloomberg: DR0 GR Return Potential 40.2% ISIN: DE000A0XYG76

26 October 2017 Energiekontor AG. FIRST BERLIN Equity Research. Update. Bloomberg: EKT GR Return Potential 67.2% ISIN: DE

EQUINET INVESTIGATOR

Leading Industrial IT set for growth

18 May 2018 Pharming Group NV. FIRST BERLIN Equity Research

6 June 2018 Formycon AG. FIRST BERLIN Equity Research. Germany / Biopharmaceuticals Xetra Bloomberg: FYB GR Return Potential 44.2% ISIN: DE000A1EWVY8

Aroundtown SA LATEST RUN RATES CONFIRM GROWTH PHASE. FIRST BERLIN Equity Research. Operational PRICE TARGET Ar ou

24 September 2018 OpenLimit Holding AG. FIRST BERLIN Equity Research

8 May 2018 Formycon AG. FIRST BERLIN Equity Research. Germany / Biopharmaceuticals Xetra Bloomberg: FYB GR Return Potential 36.3% ISIN: DE000A1EWVY8

7 March 2017 Sirona Biochem Corp. FIRST BERLIN Equity Research FY16. PRICE TARGET C$0.95 Secondary: Quotation Board Frankfurt.

BREAKDOWN Sales 2008/09 CHF mns Change Share - by segment Industrial % 92% Automotive % 8% Total % 100%

ContextVision. Solid 2Q and more details on the contract awaited. August 18 th 2014 Share price: NOK Target: NOK Risk: Medium.

Transcription:

Recommendation: BUY(BUY) Risk: HIGH (HIGH) Price Target: EUR 20.60 (20.60) 07 April 2011 Solid FY10 & More to come Final FY10 results: On 31 March 2011 Vectron announced final FY10 results which confirmed the preliminary numbers released mid of March. Driven by domestic business, sales came in at EUR 22.0m (our estimates: EUR 22.0m), indicating a yoy increase of 7.4%. The weak spot continues to be the company s international business which experienced a yoy decline of around 4.9% (FY10: EUR 7.7m vs. FY09: EUR 8.1m) while its domestic business grew by more than 15%. The vast majority of sales were generated with POS systems contributing more than 75% to the overall company sales. Slightly improving margins: In the bottom line, Vectron generated net income of EUR 0.3m beating prior year s EUR 0.1m (our estimates: EUR 0.4m). Due to lower depreciation and amortization expenses EBIT margin improved slightly to 4.3% from 3.8% in FY09, achieving EUR 0.9m in FY10. Given positive operating CF of EUR 1.7m, Cash and cash equivalents surged almost by EUR 1.4m to EUR 7.7m at the end of FY10. Thus the management runs business with a net cash position of EUR 1.1m. Given the strong operating cash flow the management will propose a dividend of EUR 0.30/share for FY10 to the shareholders at the annual general meeting. Positive on upcoming FYs: We continue to take a positive view on Vectron as we believe following measures such as 1) the introduction of new stationary POS systems, 2) the international business expansion and 3) the introduction of bonvito (potentials highlighted in our last update published on 25 March 2011) will propel top line and margins in upcoming FYs. However due to initial investments in bonvito marketing campaign (announcement of Bitburger Group as first customer) we slightly reduce our operating margins for FY11E as portrayed in our change table on the RHS. However going forward into FY12E, we expect positive top line and margin contribution from bonvito and hence increase our estimates accordingly. Recommendation: With return to its past dividend policy (payout ratio of ~80% prior to FY09) and evolving growth in company s underlying business we think the stock should attract more investors, going forward. Thus we stick to our BUY recommendation and PT of EUR 20.60/share. Change Share price (dark) vs. TecDAX Sources: CBS Research AG, Bloomberg Internet: www. vectron.de WKN: A0KEXC Reuters: V3SG.DE Company profile: 2010 2011E 2012E new old new old new old Sales 22.0 - - 24.5 28.7 27.3 EBIT 0.9-1.9 2.5 4.0 3.8 EPS 0.20-0.61 0.88 1.69 1.50 Share data: Share price (EUR, last closing price): Shares outstanding (in thousands): Market capitalisation (EURm): Enterprise value (EURm): Ø daily trading volume (6 m., no. of shares): Performance data: High 52 weeks (EUR): Low 52 weeks (EUR): Absolute performance: (12 months) Relative performance (vs. TecDAX): 1 month 3 months 12 months Sector: Technology ISIN: DE000 A0KEXC7 Bloomberg: V3S GY Vectron Systems AG is a leading provider of intelligent POS systems for the networking of branch shops. With an installation basis of more than 100,000 POS systems, Vectron belongs to the top European manufacturers and is market leader in the German catering trade and bakery industry. 14.75 1,500 22.1 21.0 2,110 16.49 11.67-1.7% 9.9% 0.7% -9.9% Key data Y/E 31.12., EUR m 2008 2009 2010 2011E 2012E Total output 23.6 20.6 22.0 24.5 28.7 EBITDA 5.2 2.2 2.3 3.1 4.9 EBIT 3.8 0.8 0.9 1.9 4.0 Net result 2.6 0.1 0.3 0.9 2.5 EPS 1.71 0.07 0.20 0.61 1.69 DPS 1.40 0.00 0.30 0.36 1.25 Gross margin 63.2% 60.5% 60.0% 60.0% 60.3% EBIT margin 16.1% 3.8% 4.3% 7.8% 14.0% EV/EBITDA 4.0 9.4 9.1 6.8 4.3 EV/EBIT 5.5 26.7 22.3 11.0 5.2 P/E 8.6 225.5 73.8 24.2 8.7 Source: CBS Research AG, Vectron Systems AG Shareholders: Jens Reckendorf Thomas Stümmler Jochen Fischer Free float 32.9% 32.9% 6.0% 28.2% Financial calendar: 1Q110 results 29 April 2011 Author: Veysel Taze (Analyst) Close Brothers Seydler Research AG Phone: +49 (0)69-977 84 56 0 E-Mail: research@cbseydlerresearch.ag www.cbseydlerresearch.ag Please notice the information on the preparation of this document, the disclaimer, the advice regarding possible conflicts of interests, and the mandatory information required by 34b WpHG (Securities Trading Law) at the end of this document. This financial analysis in accordance with 34b WpHG is exclusively intended for distribution to individuals that buy or sell financial instruments at their own account or at the account of others in connection with their trading activities, occupation, or employment.

Profit and loss account HGB EUR 1,000 2008 2009 2010 2011E 2012E Sales 23,597 20,515 22,028 24,451 28,730 YoY grow th -7.2% -13.1% 7.4% 11.0% 17.5% Inventory changes 19 44 5 0 0 Other own work capitalized 0 0 0 0 0 Total output 23,616 20,559 22,033 24,451 28,730 Cost of materials -8,702-8,129-8,811-9,780-11,406 as % of total output -36.8% -39.5% -40.0% -40.0% -39.7% Gross profit 14,914 12,430 13,222 14,671 17,324 as % of total output 63.2% 60.5% 60.0% 60.0% 60.3% Personnel expenses -4,558-4,919-5,193-5,379-5,869 as % of total output -19.3% -23.9% -23.6% -22.0% -20.4% Other operating income 208 175 216 171 144 as % of total output 0.9% 0.8% 1.0% 0.7% 0.5% Other operating expenses -5,366-5,449-5,933-6,382-6,723 as % of total output -22.7% -26.5% -26.9% -26.1% -23.4% EBITDA 5,198 2,237 2,312 3,081 4,875 as % of total output 22.0% 10.9% 10.5% 12.6% 17.0% Depreciation and amortization -1,385-1,451-1,369-1,172-850 as % of total output -5.9% -7.1% -6.2% -4.8% -3.0% EBIT 3,813 785 943 1,909 4,026 as % of total output 16.1% 3.8% 4.3% 7.8% 14.0% Net financial result 189 40 66 69 55 EBT 4,002 825 1,009 1,978 4,081 as % of total output 16.9% 4.0% 4.6% 8.1% 14.2% Income taxes -1,164-264 -176-593 -1,224 as % of EBT -29.1% -32.0% -17.5% -30.0% -30.0% Other taxes (reclassified as operational) -4.0-15.1-5.9 0.0 0.0 Net income 2,834 546 827 1,385 2,857 as % of total output 12.0% 2.7% 3.8% 5.7% 9.9% Profit transfer agreement -130-129 -163-143 0 Jouissance right compensations -146-318 -364-327 -327 Net income attributable to shareholders 2,559 98 300 915 2,530 as % of total output 10.8% 0.5% 1.4% 3.7% 8.8% Weighted average shares outstanding (in thousands) 1,500 1,500 1,500 1,500 1,500 Basic earnings per share (EUR) 1.71 0.07 0.20 0.61 1.69 Dividend per share 1.40 0.00 0.30 0.36 1.25 Source: Vectron Systems, CBS Research AG www.cbseydlerresearch.ag Close Brothers Seydler Research AG 2

Balance sheet HGB EUR 1,000 2008 2009 2010 2011E 2012E Assets Noncurrent assets 4,957 3,807 2,762 2,323 2,393 as % of total assets 26.9% 24.4% 17.3% 13.9% 13.5% Intangible assets 4,168 3,080 2,107 1,499 1,416 Property, plant and equipment 768 707 635 805 958 Financial assets 21 20 19 19 19 Current assets 13,463 11,788 13,172 14,450 15,282 as % of total assets 73.1% 75.6% 82.7% 86.1% 86.5% Inventories 2,382 2,198 2,314 2,567 3,017 Trade accounts receivable 3,217 2,946 2,773 3,349 3,936 Other current receivables and assets 104 77 211 122 172 Other assets 121 278 210 278 278 Cash and cash equivalents 7,639 6,289 7,664 8,133 7,879 Total assets 18,420 15,595 15,934 16,774 17,675 Shareholders equity and liabilities Shareholders equity 12,244 10,242 10,542 11,007 12,996 as % of total equity and liabilities 66.5% 65.7% 66.2% 65.6% 73.5% Capital stock 1,500 1,500 1,500 1,500 1,500 Capital reserve 4,500 4,500 4,500 4,500 4,500 Retained earnings 40 40 40 40 40 Unappropriated surplus 3,168 1,166.242 1,466 1,931 3,920 Jouissance right capital 3,036 3,036 3,036 3,036 3,036 Noncurrent liabilities 5,370 4,338 4,270 4,627 3,359 as % of total equity and liabilities 29.2% 27.8% 26.8% 27.6% 19.0% Provisions 1,870 838 770 1,127 1,359 Undisclosed Partnership 1,500 1,500 1,500 1,500 0 Jouissance right capital II 2,000 2,000 2,000 2,000 2,000 Liabilities 806 1,015 1,123 1,140 1,320 as % of total equity and liabilities 4.4% 6.5% 7.0% 6.8% 7.5% Trade accounts payable 518 504 810 589 687 Other liabilities 288 510 313 550 632 Total equity and liabilities 18,420 15,595 15,934 16,774 17,675 Source: Vectron Systems, CBS Research AG www.cbseydlerresearch.ag Close Brothers Seydler Research AG 3

Cash flow statement HGB EUR 1,000 2008 2009 2010 2011E 2012E Profit/loss on ordinary activities 2,559 98 300 915 2,530 Tax expenses/income 1,164 264 176 593 1,224 Cash taxes paid/received -2,659-1,352-347 -533-1,020 Depreciation and amortization 1,385 1,453 1,370 1,172 850 Other non cash items -36.752-10.8 24.8 0 0 Change in accruals -274 109-92 236 28 Extraordinary items -49 0 0 0 0 Gains/Losses from disposal of assets 0 0 0 0 0 "Cash flow" 2,089 561 1,431 2,383 3,611 Increase/decrease in inventories, trade receivables, and other assets Increase/decrease in trade accounts payable and other liabilities -68 497-73 -747-1,086-136 -5 340 17 180 Cash flow from operating activities 1,885 1,053 1,699 1,653 2,705 Net cash outflows from the purchase and retirement of PP&E and intangible assets Net cash outflows from the purchase and sale of consolidated companies -682-303 -324-734 -919 0 0 0 0 0 Cash flow from investing activities -682-303 -324-734 -919 Cash inflow from capital stock increases Dividends paid Proceeds from undisclosed partnership Proceeds from jouissance rigt capital Net borrowings/retirements of financial debt 0 0 0 0 0-2,400-2,100 0-450 -540 0 0 0 0-1,500 2,000 0 0 0 0-21 0 0 0 0 Cash flow from financing activities -421-2,100 0-450 -2,040 Total change in cash and cash equivalents 782-1,350 1,375 470-254 Cash and cash equivalents at the start of the period 6,857 7,639 6,289 7,664 8,133 Cash and cash equivalents at the end of the period 7,639 6,289 7,664 8,133 7,879 Source: Vectron Systems, CBS Research AG www.cbseydlerresearch.ag Close Brothers Seydler Research AG 4

Research Schillerstrasse 27-29 60313 Frankfurt am Main Phone: +49 (0)69 977 8456-0 Roger Peeters +49 (0)69-977 8456-12 Member of the Board Roger.Peeters@cbseydlerresearch.ag Martin Decot +49 (0)69-977 8456-13 Kristina Kardum +49 (0)69-977 8456-21 Martin.Decot@cbseydlerresearch.ag Kristina.Kardum@cbseydlerresearch.ag Rabeya Khan +49 (0)69-977 8456-10 Igor Kim +49 (0)69-977 8456-15 Rabeya.Khan@cbseydlerresearch.ag Igor.Kim@cbseydlerresearch.ag Ralf Marinoni +49 (0)69-977 8456-17 Manuel Martin +49 (0)69-977 8456-16 Ralf.Marinoni@cbseydlerresearch.ag Manuel.Martin@cbseydlerresearch.ag Enid Omerovic +49 (0)69-977 8456-19 Marcus Silbe +49 (0)69-977 8456-14 Enid.Omerovic@cbseydlerresearch.ag Marcus.Silbe@cbseydlerresearch.ag Veysel Taze +49 (0)69-977 8456-18 Veysel.Taze@cbseydlerresearch.ag Institutional Sales Schillerstrasse 27 29 25 Dowgate Hill 60313 Frankfurt am Main London EC4R 2GA Phone: +49 (0)69 9 20 54-400 Raimar Bock +49 (0)69-9 20 54-115 Head of Sales Raimar.Bock@cbseydler.com Henriette Domhardt +49 (0)69-9 20 54-137 Rüdiger Eich +49 (0)69-9 20 54-119 (Germany) Henriette.Domhardt@cbseydler.com (Germany, Switzerland) Ruediger.Eich@cbseydler.com Uwe Gerhardt +49 (0)69-9 20 54-168 Klaus Korzilius +49 (0)69-9 20 54-114 (Germany, Switzerland) Uwe.Gerhardt@cbseydler.com (Austria, Benelux, Germany) Klaus.Korzilius@cbseydler.com Stefan Krewinkel +49 (0)69-9 20 54-118 Markus Laifle +49 (0)69-9 20 54-120 (Execution, UK) Stefan.Krewinkel@cbseydler.com (Execution) Markus.Laifle@cbseydler.com Bruno de Lencquesaing +49 (0)69-9 20 54-116 Janine Theobald +49 (0)69-9 20 54-106 (Benelux, France) Bruno.deLencquesaing@cbseydler.com (Austria, Benelux, Germany) Janine.Theobald@cbseydler.com www.cbseydlerresearch.ag Close Brothers Seydler Research AG 5

Disclaimer and statement according to 34b German Securities Trading Act ( Wertpapierhandelsgesetz ) in combination with the provisions on financial analysis ( Finanzanalyseverordnung FinAnV) This report has been prepared independently of the company analysed by Close Brothers Seydler Research AG and/ or its cooperation partners and the analyst(s) mentioned on the front page (hereafter all are jointly and/or individually called the author ). None of Close Brothers Seydler Research AG, Close Brothers Seydler Bank AG or its cooperation partners, the Company or its shareholders has independently verified any of the information given in this document. Section 34b of the German Securities Trading Act in combination with the FinAnV requires an enterprise preparing a security analysis to point out possible conflicts of interest with respect to the company that is the subject of the analysis. Close Brothers Seydler Research AG is a majority owned subsidiary of Close Brothers Seydler Bank AG (hereafter CBS ). However, Close Brothers Seydler Research AG (hereafter CBSR ) provides its research work independent from CBS. CBS is offering a wide range of Services not only including investment banking services and liquidity providing services (designated sponsoring). CBS or CBSR may possess relations to the covered companies as follows (additional information and disclosures will be made available upon request): a. CBS holds more than 5% interest in the capital stock of the company that is subject of the analysis. b. CBS was a participant in the management of a (co)consortium in a selling agent function for the issuance of financial instruments, which themselves or their issuer is the subject of this financial analysis within the last twelve months. c. CBS has provided investment banking and/or consulting services during the last 12 months for the company analysed for which compensation has been or will be paid for. d. CBS acts as designated sponsor for the company's securities on the basis of an existing designated sponsorship contract. The services include the provision of bid and ask offers. Due to the designated sponsoring service agreement CBS may regularly possess shares of the company and receives a compensation and/ or provision for its services. e. The designated sponsor service agreement includes a contractually agreed provision for research services. f. CBSR and the analysed company have a contractual agreement about the preparation of research reports. CBSR receives a compensation in return. g. CBS has a significant financial interest in relation to the company that is subject of this analysis. In this report, the following conflicts of interests are given at the time, when the report has been published: d,f CBS and/or its employees or clients may take positions in, and may make purchases and/ or sales as principal or agent in the securities or related financial instruments discussed in this analysis. CBS may provide investment banking, consulting, and/ or other services to and/ or serve as directors of the companies referred to in this analysis. No part of the authors compensation was, is or will be directly or indirectly related to the recommendations or views expressed. Recommendation System: Close Brothers Seydler Research AG uses a 3-level absolute share rating system. The ratings pertain to a time horizon of up to 6 months: BUY: The expected performance of the share price is above +10%. HOLD: The expected performance of the share price is between 0% and +10%. SELL: The expected performance of the share price is below 0%. Recommendation history over the last 12 months for the company analysed in this report: Date Recommendation Price at change date Price Target 07 April 2011 BUY (update) EUR 14.75 EUR 20.60 25 March 2011 BUY (update) EUR 14.62 EUR 20.60 21 October 2010 BUY (Update) EUR 14.40 EUR 20.60 02 August 2010 BUY (Update) EUR 12.50 EUR 20.60 14 April 2010 BUY (Update) EUR 14.53 EUR 20.60 09 March 2010 BUY (Update) EUR 11.45 EUR 20.71 Risk-scaling System: www.cbseydlerresearch.ag Close Brothers Seydler Research AG 6

Close Brothers Seydler Research AG uses a 3-level risk-scaling System. The ratings pertain to a time horizon of up to 6 months: LOW: The volatility is expected to be lower than the volatility of the benchmark MEDIUM: The volatility is expected to be equal to the volatility of the benchmark HIGH: The volatility is expected to be higher than the volatility of the benchmark The following valuation methods are used when valuing companies: Multiplier models (price/earnings, price/cash flow, price/book value, EV/Sales, EV/EBIT, EV/EBITA, EV/EBITDA), peer group comparisons, historical valuation approaches, discounting models (DCF, DDM), break-up value approaches or asset valuation approaches. The valuation models are dependent upon macroeconomic measures such as interest, currencies, raw materials and assumptions concerning the economy. In addition, market moods influence the valuation of companies. The figures taken from the income statement, the cash flow statement and the balance sheet upon which the evaluation of companies is based are estimates referring to given dates and therefore subject to risks. These may change at any time without prior notice. The opinions and forecasts contained in this report are those of the author alone. Material sources of information for preparing this report are publications in domestic and foreign media such as information services (including but not limited to Reuters, VWD, Bloomberg, DPA-AFX), business press (including but not limited to Börsenzeitung, Handelsblatt, Frankfurter Allgemeine Zeitung, Financial Times), professional publications, published statistics, rating agencies as well as publications of the analysed issuers. Furthermore, discussions were held with the management for the purpose of preparing the analysis. Potentially parts of the analysis have been provided to the issuer prior to going to press; no significant changes were made afterwards, however. Any information in this report is based on data considered to be reliable, but no representations or guarantees are made by the author with regard to the accuracy or completeness of the data. The opinions and estimates contained herein constitute our best judgment at this date and time, and are subject to change without notice. Possible errors or incompleteness of the information do not constitute grounds for liability, neither with regard to indirect nor to direct or consequential damages. The views presented on the covered company accurately reflect the personal views of the author. All employees of the author's company who are involved with the preparation and/or the offering of financial analyzes are subject to internal compliance regulations. The report is for information purposes, it is not intended to be and should not be construed as a recommendation, offer or solicitation to acquire, or dispose of, any of the securities mentioned in this report. Any reference to past performance should not be taken as indication of future performance. The author does not accept any liability whatsoever for any direct or consequential loss arising from any use of material contained in this report. The report is confidential and it is submitted to selected recipients only. The report is prepared for professional investors only and it is not intended for private investors. Consequently, it should not be distributed to any such persons. Also, the report may be communicated electronically before physical copies are available. It may not be reproduced (in whole or in part) to any other investment firm or any other individual person without the prior written approval from the author. The author is not registered in the United Kingdom nor with any U.S. regulatory body. It has not been determined in advance whether and in what intervals this report will be updated. Unless otherwise stated current prices refer to the closing price of the previous trading day. Any reference to past performance should not be taken as indication of future performance. The author maintains the right to change his opinions without notice, i.e. the opinions given reflect the author s judgment on the date of this report. This analysis is intended to provide information to assist institutional investors in making their own investment decisions, not to provide investment advice to any specific investor. By accepting this report the recipient accepts that the above restrictions are binding. German law shall be applicable and court of jurisdiction for all disputes shall be Frankfurt am Main (Germany). This report should be made available in the United States solely to investors that are (i) "major US institutional investors" (within the meaning of SEC Rule 15a-6 and applicable interpretations relating thereto) that are also "qualified institutional buyers" (QIBs) within the meaning of SEC Rule 144A promulgated by the United States Securities and Exchange Commission pursuant to the Securities Act of 1933, as amended (the "Securities Act") or (ii) investors that are not "US Persons" within the meaning of Regulation S under the Securities Act and applicable interpretations relating thereto. The offer or sale of certain securities in the United States may be made to QIBs in reliance on Rule 144A. Such securities may include those offered and sold outside the United States in transactions intended to be exempt from registration pursuant to Regulation S. This report does not constitute in any way an offer or a solicitation of interest in any securities to be offered or sold pursuant to Regulation S. Any such securities may not be offered or sold to US Persons at this time and may be resold to US Persons only if such securities are registered under the Securities Act of 1933, as amended, and applicable state securities laws, or pursuant to an exemption from registration. This publication is for distribution in or from the United Kingdom only to persons who are authorised persons or exempted persons within the meaning of the Financial Services and Markets Act 2000 of the United Kingdom or any order made there under or to investment professionals as defined in Section 19 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and is not intended to be distributed or passed on, directly or indirectly, to any other class of persons. This publication is for distribution in Canada only to pension funds, mutual funds, banks, asset managers and insurance companies. www.cbseydlerresearch.ag Close Brothers Seydler Research AG 7

The distribution of this publication in other jurisdictions may be restricted by law, and persons into whose possession this publication comes should inform themselves about, and observe, any such restrictions. In particular this publication may not be sent into or distributed, directly or indirectly, in Japan or to any resident thereof. Responsible Supervisory Authority: Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin, Federal Financial Supervisory Authority) Graurheindorferstraße 108 53117 Bonn and Lurgiallee 12 60439 Frankfurt Schillerstrasse 27-29 60313 Frankfurt am Main www.cbseydlerresearch.ag Tel.: 0049 - (0)69-97 78 45 60 www.cbseydlerresearch.ag Close Brothers Seydler Research AG 8